izpis_h1_title_alt

Oral lyophilizates obtained using aggressive drying conditions : effect of excipients
ID Bjelošević Žiberna, Maja (Author), ID Planinšek, Odon (Author), ID Ahlin Grabnar, Pegi (Author)

.pdfPDF - Presentation file, Download (2,77 MB)
MD5: 54DCB5FD461E67EF896B07852C1A1C32
URLURL - Source URL, Visit https://www.sciencedirect.com/science/article/pii/S1773224723002319 This link opens in a new window

Abstract
Orodispersible drug formulations are a current trend in the pharmaceutical industry, mostly intended for pediatric and geriatric patients. Oral lyophilizates are solid forms, intended either to be placed in the mouth or to be dispersed (or dissolved) in water before administration. The correct excipient composition is a prerequisite to provide lyophilizates with the appropriate visual appearance and disintegration time. Typically, they are composed of binders, such as gelatin and polyvinylpyrrolidone, fillers such as sucrose, mannitol, or sorbitol, taste modifiers, colorants, sweeteners, and preservatives. The main purpose of this study was to determine the optimal excipient scaffold to ensure the proper appearance of lyophilizates that have undergone aggressive drying conditions and a disintegration time of less than 3 min. In addition to mannitol and gelatin, the most frequently used binders, PVP K25, PVP K90, glycine, croscarmellose, and hydrolyzed gelatin were investigated. The results obtained revealed that lyophilizates with only mannitol and gelatin have a disintegration time that is too long, and that replacement of gelatin with PVP K25 led to friable and cracked lyophilizates. Considering disintegration time and visual appearance, lyophilizates with a mixture of gelatin, PVP K25, and mannitol (1:2:5) formed from liquid formulations with 6% (w/w) excipients were determined to be the most suitable. As a binder, PVP K25 expresses more appropriate characteristics relating to PVP K90. Addition of croscarmellose provided lyophilizates with a shorter disintegration time, whereas glycine only had a positive effect on the elegant appearance of lyophilizate cakes. Hydrolyzed gelatin was introduced with the aim of obtaining an even shorter disintegration time and at the same time an acceptable visual appearance of lyophilizates. This was achieved by lyophilization of solutions with 15% (w/w) of excipients with a hydrolyzed gelatin:PVP K25:glycine/croscarmellose:mannitol ratio of 4:2:0.5:4.5. Such lyophilizates show the highest potential for incorporation of poorly soluble and low-dose drugs.

Language:English
Keywords:patient-friendly dosage forms, orodispersible dosage forms, oral lyophilizates, excipient selection, hydrolyzed gelatin, aggressive drying
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:8 str.
Numbering:Vol. 82, art. 104379
PID:20.500.12556/RUL-144903 This link opens in a new window
UDC:661.12
ISSN on article:1773-2247
DOI:10.1016/j.jddst.2023.104379 This link opens in a new window
COBISS.SI-ID:146036995 This link opens in a new window
Publication date in RUL:22.03.2023
Views:401
Downloads:70
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Journal of drug delivery science and technology
Shortened title:J. drug deliv. sci. technol.
Publisher:Elsevier
ISSN:1773-2247
COBISS.SI-ID:2045297 This link opens in a new window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Secondary language

Language:Slovenian
Keywords:pacientom prijazne dozirne oblike, orodisperzibilne dozirne oblike, peroralni liofilizati, izbor pomožnih snovi, hidrolizirana želatina, agresivno sušenje, farmacevtska industrija

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0189
Name:Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih

Funder:ARRS - Slovenian Research Agency
Project number:L1-3160
Name:Razvoj visokokoncentriranih proteinskih formulacij in vrednotenje kinetike absorpcije po subkutani aplikaciji

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back